Minzasolmin
Minzasolmin (DLX-313) is a small molecule inhibitor that targets the misfolding of alpha-synuclein. It is a research tool used in both in vitro and in vivo studies to investigate the pathological mechanisms and potential therapeutic strategies for Parkinson's disease.
Product Specifications
CAS Number
1802518-92-8
Product Name Alternative
DLX-313, (R) -NPT200-11, UCB0599, α-synuclein
Purity
98.31% (May vary between batches)
Smiles
C ([C@H] (NC (=O) C=1SC (=NC1) N2CCN (C) CC2) CCCC) C=3C=4C (NC3) =CC=CC4
Molecular Formula
C23H31N5OS
Molecular Weight
425.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9614-Fluoro594 100 µg/Vial
Anti-MNAT1 Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details K0764108 1.0 µg DNA
FBXO8 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
NSL0930r 96 Tests
Rat Anti-mutated citrullinated vimentin Anti-body (MCV) ELISA Kit
Sign In for Pricing
View Details ![5-{[ (4-Methylphenyl) methyl]amino}-2,3-dihydro-1H-1,3-benzodiazol-2-one](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
TQA12730-01 50 mg
5-{[ (4-Methylphenyl) methyl]amino}-2,3-dihydro-1H-1,3-benzodiazol-2-one
Sign In for Pricing
View Details TQA12730-02 0.5 g
5-{[ (4-Methylphenyl) methyl]amino}-2,3-dihydro-1H-1,3-benzodiazol-2-one
Sign In for Pricing
View Details